Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.01 | N/A |
PEG Ratio (TTM) | 0.11 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 1.41 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 11.38% | N/A |
ROE (TTM) | 12.26% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 699.94% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 2,137.08% | N/A | N/A |
Cash Flow | -24,066.13% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.22 | N/A |
Quick Ratio (TTM) | 0.22 | N/A |
D/E Ratio (TTM) | 0.00 | N/A |
Interest Coverage (TTM) | 0.09 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 13.45 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |